Form D · Other Health Care
ENDOSTIM, INC.
Dallas, TX · CIK 0001469166
Offering snapshot reported Dec 31, 2018 · SEC filing
- Reported sold
- $2.81M Offering amount: $7M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 17, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 31, 2018 | Initial | $2,808,000 | No comparison | 4 | SEC filing |
| Jan 16, 2018 | Amendment | $12,149,119 | $0vs Jan 12, 2018 | 20 | SEC filing |
| Jan 12, 2018 | Initial | $12,149,119 | No comparison | 20 | SEC filing |
| Mar 23, 2016 | Initial | $11,063,742 | No comparison | 83 | SEC filing |
| May 8, 2015 | Initial | $2,500,003 | No comparison | 1 | SEC filing |
| Jul 10, 2014 | Initial | $6,364,780 | No comparison | 72 | SEC filing |
| May 29, 2013 | Amendment | $14,080,174 | $1,325,258vs Apr 23, 2013 | 81 | SEC filing |
| Apr 23, 2013 | Amendment | $12,754,916 | $1,544,842vs Mar 19, 2013 | 72 | SEC filing |
| Mar 19, 2013 | Amendment | $11,210,074 | $3,051,919vs Dec 14, 2012 | 67 | SEC filing |
| Jan 14, 2013 | Amendment | $9,133,808 | $975,653vs Dec 14, 2012 | 56 | SEC filing |
| Dec 14, 2012 | Initial | $8,158,155 | No comparison | 41 | SEC filing |
| Dec 5, 2011 | Initial | $5,548,991 | No comparison | 10 | SEC filing |
| Jul 30, 2010 | Initial | $5,999,926 | No comparison | 26 | SEC filing |
| Oct 1, 2009 | Initial | $775,000 | No comparison | 16 | SEC filing |
| Jul 28, 2009 | Initial | $550,000 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-329283
Source: Form D, filed Dec 31, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ralph G. Dacey | Director |
| Brian Farley | Director |
| Doug French | Director |
| Douglas D. French | Director |
| Fred C. Goad | Director |
| Paul V. Goode | Executive |
| Rohan J. Hoare | Director, Executive |
| Bevil J. Hogg | Director, Executive |
| Jeffrey M. Mc Donnell | Director |
| Raul E. Perez | Director |
| Kimberly Pinson | Executive |
| Shai Policker | Executive |
| Alexander Schmitz | Director |
| Sarah Sharma | Director |
| Virender K. Sharma | Executive |
| Peggy S. Stohr | Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
4104 Mc Ewen Drive Suite 336
Dallas, TX, 75244
Phone: 469-680-3090
Dallas, TX, 75244
Phone: 469-680-3090